drugset / Trial / NCT03669484

Comparative Clinical Study of Efficacy and Safety of Remimazolam and Propofol in Patients Undergoing Elective Surgery Under General Anaesthesia

NCT03669484

Phase 3 Completed 150 enrolled R-Pharm Synergy Research Group · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study was to perform comparative evaluation of clinical efficacy and safety of Remimazolam and Propofol for induction and maintenance of general anesthesia in patients undergoing elective surgery under general anaesthesia.

Timeline

Start
2017-08-22
Primary completion
2018-05-15
Completion
2018-05-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule 4 mg/kg Intravenous
Comparator Propofol Small molecule 12 mg/kg Intravenous
Subject Remimazolam Small molecule 1 mg/kg Intravenous
Background Fentanyl Other / unclassified 2 mg/kg Intravenous
Background Rocuronium Other / unclassified 0.6 mg/kg Intravenous
Background Rocuronium Other / unclassified 0.9 mg/kg Intravenous

Indications

No indication recorded.